The patient monitoring market includes diagnostic and measurement devices, exhalation monitors, multiparameter patient monitoring, neonatal monitors, operating room Integration systems, and remote patient monitoring. The Cardiology Remote Monitor device is worn externally by the patient. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cardio remote monitoring devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the cardio remote monitoring market in Australia was GE Healthcare followed by Shenzhen Mindray Bio-Medical Electronics and Nihon Kohden.
The Cardiology Remote Monitor device consists of a recording device and electrodes to capture the electronic impulses of the heart and record the ECG data in the external device.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the cardio remote monitoring devices market within Australia was expected to be over $10m in 2022.
For the latest complete market share analysis of cardio remote monitoring device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
